AbbVie (ABBV) Stock Forecast & Price Target
Score
AbbVie Inc. price target
| ABBV | |
|---|---|
| Low | $235.00 |
| Average | $308.88 |
| High | $340.00 |
| Upside vs current price | +4.7% |
The average target of $308.88 is +4.7% versus the current ABBV price of $294.98.
AbbVie Inc. analyst ratings
| Rating | Analysts |
|---|---|
| Strong buy | 7 |
| Buy | 16 |
| Hold | 5 |
| Sell | 0 |
| Strong sell | 1 |
| Consensus | Buy |
29 analysts cover ABBV.
AbbVie Inc. EPS and revenue estimates
The estimate table for the AbbVie Inc. keeps 2026 EPS $13.97, 2027 EPS $16.31, and years with fewer than three analysts are not filled in.
| Fiscal year | EPS estimate | Revenue estimate |
|---|---|---|
| 2026 | $13.97 | $67.67B |
| 2027 | $16.31 | $73.67B |
Is AbbVie Inc. a buy or sell?
Of the 29 analysts covering AbbVie Inc., 23 rate it a buy (7 strong buy and 16 buy), 5 rate it a hold, and 1 rates it a sell (0 sell and 1 strong sell).
The ABBV consensus label is Buy, beside 23 buy-side ratings and 1 sell-side ratings.
The average target of $308.88 implies +4.7% versus the current price of $294.98.
the AbbVie Inc. closes with 23 buy-side ratings and 1 on the sell side. The headcount is Buy.
Reading the AbbVie Inc. forecast
Between the ABBV low of $235.00 and the high of $340.00, the average target is $308.88.
From today's $294.98 print, the ABBV average target is +4.7% away.
Most of the ABBV coverage agrees: 23 of 29 analysts are on the buy side, 5 are at hold, and 1 is on the sell side, and the published consensus is Buy.
Recent ABBV actions lean up: 2 upgrades against 0 downgrades.
ABBV targets have not moved much: $313.77 recently, $311.59 across the quarter.
Coverage of ABBV is broad at 29 analysts, and the average is a crowd rather than a single desk.
AbbVie Inc. forecast questions
What is the ABBV price target?
The published range for ABBV is $235.00 to $340.00, with an average of $308.88. That average is +4.7% versus the current price of $294.98.
Is AbbVie Inc. a buy or sell?
Of the 29 analysts covering AbbVie Inc., 23 rate it a buy, 5 rate it a hold, and 1 rates it a sell. The consensus is Buy, which for ABBV is 23 on the buy side, 5 at hold, and 1 on the sell side.
What is the EPS estimate for AbbVie Inc.?
Analyst EPS estimates for AbbVie Inc.: 2026 $13.97, 2027 $16.31.
What is the revenue estimate for AbbVie Inc.?
Analyst revenue estimates for AbbVie Inc.: 2026 $67.67B, 2027 $73.67B.
How many analysts cover ABBV?
29 analysts cover ABBV. Their consensus on ABBV is Buy, across those 29.